Jazz Pharmaceuticals plc — Director's Dealing 2012

Jan 13, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2012-01-11

Reporting Person: Cox Russell J. (SVP, Sales and Marketing)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-01-11	Common Stock	M	14800	$8.23	Acquired	16015	Direct
2012-01-11	Common Stock	F	7927	$48.60	Disposed	8088	Direct
2012-01-11	Common Stock	M	40000	$27.46	Acquired	48088	Direct
2012-01-11	Common Stock	F	29083	$48.60	Disposed	19005	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-01-11	Option (right to buy)	$8.23	M	14800	Disposed	2020-08-24	Common Stock (14800)	Direct
2012-01-11	Option (right to buy)	$27.46	M	40000	Disposed	2021-03-09	Common Stock (40000)	Direct

Footnotes

F1: Represents shares withheld by the Issuer for cashless exercise of nonstatutory stock options solely to cover exercise price and required withholding taxes.

F2: This option, consisting of a nonstatutory stock option exercisable for 14,800 shares of common stock and an incentive stock option exercisable for 45,200 shares of common stock, has a vesting schedule of one fourth vested on July 21, 2011 and the remainder vesting in 36 equal monthly installments thereafter.

F3: This nonstatutory stock option has a vesting schedule of one fourth vesting on March 1, 2012 and the remainder vesting in 36 equal monthly installments thereafter.

F4: On October 24, 2011, the Board of Directors of the Issuer approved the full vesting of unvested nonstatutory stock options held by the Issuer's officers and non-employee directors, including the Reporting Person. Such vesting acceleration became effective on December 13, 2011.